Clinical Trials

Showing 1 - 20 of 444 trials
Titlesort icon Investigator Disease(s)
A Clinical Study of McGhan Corporation-Style 410 Silicone-Filled Breast Implants
[Protocol 06-024]
Disa, Joseph
  • Breast Cancer
  • Survivorship
A Comprehensive Assessment to Predict Side Effects from Chemotherapy and an Evaluation of Pre-Phase Chemotherapy in Older Patients with Non-Hodgkin Lymphoma
[Protocol 13-028]
Hamlin, Paul
  • Lymphoma
    • Non-Hodgkin's Lymphoma
A Genotype-Phenotype Urothelial Cancer Study
[Protocol 09-025]
Bajorin, Dean
  • Bladder Cancer
  • Hereditary Cancer & Genetics
A Long-Term Study of Sexual and Reproductive Health in Women with Breast Cancer and Lymphoma
[Protocol 12-249]
Goldfarb, Shari
  • Breast Cancer
  • Lymphoma
    • Hodgkin's Disease
    • Non-Hodgkin's Lymphoma
  • Survivorship
A Multicenter Study of Sonablate 500 HIFU Treatment for Locally Recurrent Prostate Cancer: the STAR Trial
[Protocol 09-164]
Eastham, James
  • Prostate Cancer
    • Localized Disease
    • Rising PSA After Primary Therapy
A Non-Myeloablative Conditioning Regimen with Peri-Transplant Rituximab and Stem Cell Transplantation in Patients with B-cell Non-Hodgkin's Lymphoma
[Protocol 06-150]
Castro-Malaspina, Hugo
  • Blood & Marrow Stem Cell Transplantation
    • Sibling and Unrelated Volunteer
  • Lymphoma
    • Non-Hodgkin's Lymphoma
A Phase 1B/II Study of GDC-0449 Plus RO4929097 in Advanced/Metastatic Sarcomas
[Protocol 10-049]
Gounder, Mrinal
  • Sarcomas
    • Soft Tissue Sarcoma
A Phase I Dose Escalation Study Using Ultra-Hypofractionated, Image-Guided, Intensity-Modulated Radiotherapy in Prostate Cancer
[Protocol 09-035]
Zelefsky, Michael
  • Prostate Cancer
    • Localized Disease
A Phase I Dose-Escalation Study of Image-Guided Radiation Therapy for Bladder Cancer Patients Undergoing Radiotherapy and Concurrent Gemcitabine Chemotherapy
[Protocol 10-031]
Kollmeier, Marisa
  • Bladder Cancer
A Phase I Study of ABT-888 in Combination with Carboplatin and Gemcitabine in Patients with Advanced Solid Tumors
[Protocol 09-154]
Bell-McGuinn, Katherine
  • Ovarian Cancer
A Phase I Study of ABT-888 with Carboplatin and Paclitaxel in Patients with Solid Tumors Who Have Liver or Kidney Problems
[Protocol 11-118]
Hyman, David
A Phase I Study of AC220 for Children with Relapsed or Refractory Acute Leukemias
[Protocol 12-141]
Trippett, Tanya
  • Leukemia
    • Acute Lymphoblastic Leukemia
    • Acute Myelogenous Leukemia
A Phase I Study of AC220 plus Chemotherapy in Patients with Newly Diagnosed Acute Myeloid Leukemia
[Protocol 11-160]
Tallman, Martin
  • Leukemia
    • Acute Myelocytic Leukemia
    • Acute Myelogenous Leukemia
A Phase I Study of Actinium-225-Labeled HuM195 Antibody in Patients with Advanced Myeloid Malignancies
[Protocol 02-017]
Douer, Dan
  • Hematology
    • Myelodysplastic Syndrome
  • Leukemia
    • Acute Myelogenous Leukemia
    • Chronic Myelocytic Leukemia
    • Myelodysplastic Syndrome
A Phase I Study of AEB071 in Patients with CD79-Mutant Diffuse Large B-Cell Lymphoma
[Protocol 12-157]
Gerecitano, John
  • Lymphoma
    • Non-Hodgkin's Lymphoma
A Phase I Study of AEB071 in Patients with Metastatic Uveal Melanoma
[Protocol 11-167]
Schwartz, Gary
  • Melanoma
    • Melanoma of the Eye
A Phase I Study of Afatinib with Chemotherapy and Radiation Therapy in Patients with EGFR-Mutant Non-Small Cell Lung Cancer
[Protocol 12-279]
Chaft, Jamie
  • Lung Cancer, Non-Small Cell
A Phase I Study of AGS-16C3F in Patients with Clear Cell or Papillary Renal Cell Cancer
[Protocol 12-162]
Molina, Ana Maria
  • Kidney Cancer
A Phase I Study of AGS-22M6E in Patients with Malignant Solid Tumors Expressing Nectin-4
[Protocol 11-113]
Konner, Jason
A Phase I Study of AMP-224 with a Cyclophosphamide-Containing Regimen in Patients with Advanced Melanoma
[Protocol 12-127]
Dickson, Mark
  • Melanoma